Lupin tops world pharma and all Indian sectors in S&P ESG rankings
Lupin attained a score of 91 out of 100, establishing itself as the leading pharmaceutical company globally
Lupin attained a score of 91 out of 100, establishing itself as the leading pharmaceutical company globally
Zydus has developed an innovative Semaglutide Injection (15 mg/3 ml) in a prefilled cartridge administered using a patient-friendly reusable pen for which the company has exclusive rights
For the fourth quarter, revenue surged 47% year-on-year to Rs. 2,510 million, driven by a 23% rise in domestic sales and a 9.3x jump in export sales
Brivaracetam Oral Solution (10 mg/mL) is a prescription antiepileptic drug (anticonvulsant) used for treatment of partial-onset seizures in patients 1 month of age and older
Meenal brings in more than 16 years of international experience across Europe, Asia and the Middle East
Nadda underlined that India’s policy framework is aligned with this transformation
Prostate cancer is one of the fastest-growing cancers in India, with approximately 37,948 new cases each year
The product will target Type 2 diabetes management aligning with unmet needs in India’s expanding metabolic care landscape
The MoU lays the groundwork for deep academic and research collaboration in pharmaceutical technologies
The new lineup features everything from the Color Fixation and Hair Therapy ranges to the Balanced Cleansing Shampoo and Nourishment & Protection Conditioner
Subscribe To Our Newsletter & Stay Updated